日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote

由复合型 CCR5Δ32 和 CCR5 C20S 杂合子赋予的对人类免疫缺陷病毒 1 型感染的抵抗力

Alkhatib, Bashar; Jabari, Mary; Bilasy, Shymaa; Abdul-Rahman, Husni; Sandhu, Kamal; Lai, Stephen; Alkhatib, Ghalib

Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient

HIV-1包膜介导的融合水平低与感染CCR5-/-患者的长期生存相关。

Gorry, Paul R; Ahmad, Fahim; Mohl, Jon; Alkhatib, Ghalib

The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalization

CXCL12γ 强大的抗 HIV 活性与其高效的 CXCR4 结合和内化作用密切相关。

Altenburg, Jeffrey D; Jin, Qingwen; Alkhatib, Bashar; Alkhatib, Ghalib

Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome

反驳观点:脐带血干细胞疗法治疗获得性免疫缺陷综合征

Alkhatib, Ghalib

Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors

尽管HIV-1辅助受体表达可检测,但通过慢病毒载体介导递送CCR5Δ32基因产生的对1型人类免疫缺陷病毒(HIV-1)的抵抗力

Jin, Qingwen; Marsh, Jon; Cornetta, Kenneth; Alkhatib, Ghalib

A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.

CXCL12/基质细胞衍生因子 1 的一种天然剪接变体是一种强效的人类免疫缺陷病毒 1 型抑制剂,具有较弱的趋化性和细胞存活活性

Altenburg Jeffrey D, Broxmeyer Hal E, Jin Qingwen, Cooper Scott, Basu Sunanda, Alkhatib Ghalib

Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

CCR5Delta32 蛋白在原代 CD4+ 细胞中对 R5、R5X4 和 X4 型人类免疫缺陷病毒 1 型的抵抗作用中的作用

Agrawal Lokesh, Lu Xihua, Qingwen Jin, VanHorn-Ali Zainab, Nicolescu Ioan Vlad, McDermott David H, Murphy Philip M, Alkhatib Ghalib